Dolby Laboratories (DLB) risk factors, FY2024 10-K

Dolby Laboratories's FY2024 10-K, filed Nov 19, 2024. The risk counts for this filing are not shown yet. The filing itself is linked below.

Dolby Laboratories's biggest risks in the FY2024 10-K

  • Licensing revenue depends on OEM adoption, non-exclusive agreements, and royalty-reporting timing outside Dolby’s control.
  • International sales represent approximately 63%–65% of revenue, exposing Dolby to trade restrictions and changing foreign laws.
  • Growth depends on developing technologies for digital broadcast, mobile, online media, cinema, and cloud markets.

The risks most specific to Dolby Laboratories

  • Customers and Distributors

    OEMs and other licensees may not incorporate Dolby technologies because agreements are generally non-exclusive and often do not require use.

  • Reporting practices and uncertainty may result in fluctuations in our royalty revenue from period to period

    Royalty reports, corrective adjustments, retroactive royalties, and licensing revenue-recognition timing can cause substantial period-to-period revenue fluctuations.

  • TECHNOLOGY TRENDS AND DEVELOPMENTS

    Dolby may fail to develop successful technologies for digital broadcast, mobile devices, online media, cinema, or cloud services.

  • LEGAL AND REGULATORY COMPLIANCE

    Approximately 63%–65% of revenue comes from outside the U.S., exposing Dolby to trade restrictions and unpredictable foreign laws.

  • Any or all of these factors, and the uncertainties associated with them, may impact our ability to operate in foreign countries and our ability to develop, the demand for, and profitability of, our technologies and products, as well as our customers' products that incorporate our technologies

    Competition-law actions by foreign governments and industry participants could pressure Dolby’s intellectual-property royalty rates.

  • Moreover, the Dolby family and their affiliates may take actions in their own interests that our other stockholders do not view as beneficial

    The Dolby family and affiliates may pursue interests that other stockholders oppose, while substantial Class A share sales could depress the stock price.

Risk factor headings as read

Headings as the filing states them, in filing order.

Other

  1. 01Customers and Distributors
  2. 02Reporting practices and uncertainty may result in fluctuations in our royalty revenue from period to period
  3. 03TECHNOLOGY TRENDS AND DEVELOPMENTS
  4. 04LEGAL AND REGULATORY COMPLIANCE
  5. 05Any or all of these factors, and the uncertainties associated with them, may impact our ability to operate in foreign countries and our ability to develop, the demand for, and profitability of, our technologies and products, as well as our customers' products that incorporate our technologies
  6. 06Moreover, the Dolby family and their affiliates may take actions in their own interests that our other stockholders do not view as beneficial

Other Dolby Laboratories 10-Ks

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.